CELL-DYN EMERALD CN-FREELYSE. - COFEPRIS Registration 0793R2022 SSA
Access comprehensive regulatory information for CELL-DYN EMERALD CN-FREELYSE. (CELL-MAN EMERALD CN-FREELYSE.) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 0793R2022 SSA and manufactured by ABBOTTLABORATORIES DEMÉXICO, S.A. DE C.V.. The device was registered on August 16, 2022.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
EL CELL-DYN EMERALD CN-FREE LYSE REALIZA LOSIGUIENTE•HEMOLIZALOSERITROCITOSCONRAPIDEZYMINIMIZAELESTROMACELULARRESULTANTE.•ALTERALAMEMBRANADELOSLEUCOCITOSPARAPERMITIRQUEELCITOPLASMASEDIFUNDAYREDUCELAMEMBRANADELNÚCLEO Y TO
THE CELL-DYN EMERALD CN-FREE LYSE PERFORMS THE FOLLOWING•HEMOLYSTALALISALOSERITROCYTES RAPIDLY AND MINIMISES THE RESULTING CELLULAR STROMA.•ALTERS THE MEMBRANE OF THE LEUKOCYTES TO ALLOW THE CYTOPLASM TO DIFFUSE AND SHRINK THE MEMBRANE OF THE NUCLEUS AND TO